These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9194983)

  • 1. Adverse events and cost savings three years after implementation of guidelines for outpatient contrast-agent use.
    Grant KL; Camamo JM
    Am J Health Syst Pharm; 1997 Jun; 54(12):1395-401. PubMed ID: 9194983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective use of low-osmolality contrast media in computed tomography.
    Valls C; Andía E; Sánchez A; Moreno V
    Eur Radiol; 2003 Aug; 13(8):2000-5. PubMed ID: 12942301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
    Henry DA; Evans DB; Robertson J
    Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tolerability of contrast media used for coronary interventions.
    Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
    Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty.
    Keuffel E; McCullough PA; Todoran TM; Brilakis ES; Palli SR; Ryan MP; Gunnarsson C
    J Med Econ; 2018 Apr; 21(4):356-364. PubMed ID: 29226736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
    Hunter TB; Dye J; Duval JF
    AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and safety of selective use of low-osmolality contrast media.
    Michalson A; Franken EA; Smith W
    Acad Radiol; 1994 Sep; 1(1):59-62. PubMed ID: 9419466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic versus nonionic contrast media: a prospective study of the effect of rapid bolus injection on nausea and anaphylactoid reactions.
    Federle MP; Willis LL; Swanson DP
    J Comput Assist Tomogr; 1998; 22(3):341-5. PubMed ID: 9606371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low osmolar (non-ionic) contrast media versus high osmolar (ionic) contrast media in intravenous urography and enhanced computerized tomography: a cost-effectiveness analysis.
    Wangsuphachart S
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):664-76. PubMed ID: 1820658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of high- and low-osmolality contrast media on renal function in children].
    Chen CY; Cao L; Chen DK; Chu M; Tu J
    Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):280-4. PubMed ID: 16780650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media.
    Spinler SA; Goldfarb S
    Ann Pharmacother; 1992 Jan; 26(1):56-64. PubMed ID: 1606346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro.
    Duan S; Zhou X; Liu F; Peng Y; Chen Y; Pei Y; Ling G; Zhou L; Li Y; Pi Y; Tang K; Liu R; Li G
    J Nephrol; 2006; 19(6):717-24. PubMed ID: 17173243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-osmolality contrast media: a current perspective.
    King BF; Hartman GW; Williamson B; LeRoy AJ; Hattery RR
    Mayo Clin Proc; 1989 Aug; 64(8):976-85. PubMed ID: 2677533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography.
    Powe NR; Davidoff AJ; Moore RD; Brinker JA; Anderson GF; Litt MR; Gopalan R; Graziano SL; Steinberg EP
    J Am Coll Cardiol; 1993 Jun; 21(7):1701-9. PubMed ID: 8496540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular contrast media. Ionic versus nonionic: current status.
    McClennan BL; Stolberg HO
    Radiol Clin North Am; 1991 May; 29(3):437-54. PubMed ID: 2023999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective use of low-osmolar contrast media.
    Debatin JF; Cohan RH; Leder RA; Zakrzewski CB; Dunnick NR
    Invest Radiol; 1991 Jan; 26(1):17-21. PubMed ID: 2022448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use.
    McClennan BL
    AJR Am J Roentgenol; 1990 Aug; 155(2):225-33. PubMed ID: 2115244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of late adverse reactions to low-osmolar contrast media: A prospective observational study of 10,540 exposures.
    Kang DY; Lee SY; Ahn YH; Yoon SH; Choi YH; Lee W; Kang HR
    Eur J Radiol; 2022 Jan; 146():110101. PubMed ID: 34952368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
    Barrett BJ; Carlisle EJ
    Radiology; 1993 Jul; 188(1):171-8. PubMed ID: 8511292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of intravenous iodinated contrast media in Italy.
    Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M
    Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.